HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gwangil Kim Selected Research

Gwangil Kim Research Topics

Disease

12Neoplasms (Cancer)
10/2020 - 05/2011
8Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 11/2010
7Carcinoma (Carcinomatosis)
08/2021 - 05/2011
4Neoplasm Metastasis (Metastasis)
05/2022 - 05/2011
3Breast Neoplasms (Breast Cancer)
01/2017 - 08/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2022 - 01/2016
2Pathologic Constriction (Stenosis)
02/2022 - 01/2022
2Fibrosis (Cirrhosis)
02/2022 - 06/2017
2Bites and Stings (Sting)
01/2019 - 01/2019
2Adenocarcinoma
05/2016 - 08/2014
1Congenital Abnormalities (Deformity)
02/2022
1Infections
05/2019
1Vascular Remodeling
01/2019
1Abdominal Pregnancy
07/2017
1Tubal Pregnancy
07/2017
1Amenorrhea
07/2017
1Hemorrhage
07/2017
1Lung Neoplasms (Lung Cancer)
01/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016
1Adenocarcinoma of Lung
01/2016
1Stomach Ulcer (Gastric Ulcer)
04/2015
1Ulcer
04/2015
1Endometrial Stromal Sarcoma
12/2014
1Carcinogenesis
08/2014
1Leukemia
08/2013
1Stomach Neoplasms (Stomach Cancer)
10/2012
1Disease Progression
05/2011
1Lymphatic Metastasis
05/2011

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2017 - 05/2011
3MicroRNAs (MicroRNA)IBA
05/2022 - 11/2010
3ParaffinIBA
04/2021 - 05/2011
3Formaldehyde (Formol)FDA Link
04/2021 - 05/2011
3Indicators and Reagents (Reagents)IBA
04/2021 - 10/2012
3Paclitaxel (Taxol)FDA LinkGeneric
09/2017 - 01/2016
3Biomarkers (Surrogate Marker)IBA
01/2015 - 11/2010
2InterferonsIBA
01/2019 - 01/2019
2Interferon Type IIBA
01/2019 - 01/2019
2Small Interfering RNA (siRNA)IBA
01/2016 - 03/2014
1RNA (Ribonucleic Acid)IBA
08/2021
1micaIBA
04/2021
1LigandsIBA
04/2021
1pembrolizumabIBA
10/2020
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1LuciferasesIBA
09/2017
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
07/2017
1Fibronectins (Fibronectin)IBA
06/2017
1Troglitazone (Rezulin)FDA Link
06/2017
1Rosiglitazone (Avandia)FDA Link
06/2017
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2017
1fascinIBA
01/2017
1Transcription Factors (Transcription Factor)IBA
05/2016
1Messenger RNA (mRNA)IBA
02/2016
1human MIRN1290 microRNAIBA
01/2016
1Serum-Free Culture MediaIBA
01/2016
1human MIRN1246 microRNAIBA
01/2016
1Pharmaceutical PreparationsIBA
04/2015
1Drug CombinationsIBA
04/2015
1Phenobarbital (Luminal)FDA Link
03/2015
1Oncogene Proteins (Oncogene Protein)IBA
01/2015
1CarcinogensIBA
08/2014
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2013
1Biological ProductsIBA
08/2013
1Lysine (L-Lysine)FDA Link
08/2013
1Fluorouracil (Carac)FDA LinkGeneric
08/2013
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2013
1CyclinsIBA
05/2011
1Cell Cycle ProteinsIBA
05/2011
1Cyclin AIBA
05/2011
1Cyclin EIBA
05/2011
1Cyclin-Dependent Kinase Inhibitor p16IBA
05/2011
1Cyclin B1IBA
05/2011

Therapy/Procedure

3Therapeutics
08/2021 - 04/2015
1Stents
02/2022
1Radiofrequency Ablation
01/2022
1Pancreaticoduodenectomy
06/2019
1Surgical Instruments (Clip)
05/2019
1Immunotherapy
01/2019
1Conservative Treatment
07/2017
1Drug Therapy (Chemotherapy)
01/2016
1Aftercare (After-Treatment)
01/2016
1Photochemotherapy (Photodynamic Therapy)
12/2014